Jaguar Health, Inc. (NASDAQ:JAGX) | WebDisclosure

Basculer en Français

10645	Companies
226412	Keywords
154874	Articles
119833	Press releases

Home
Companies
Jaguar Health, Inc.

PRESS RELEASE

published on 10/24/2025 at 22:15, 8 months 1 day ago

Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jaguar Health, Inc. (NASDAQ:JAGX) granted RSUs to new employees effective October 20, 2025. RSUs vest over one year. The Company focuses on developing prescription medicines from rainforest plants for gastrointestinal distress

Gastrointestinal Distress Jaguar Health RSUs New Employees Prescription Medicines
BRIEF

published on 10/06/2025 at 15:05, 8 months 19 days ago

Jaguar Health fait progresser le développement du Crofelemer pour le traitement de la MVID lors d'une réunion de la FDA

Crofelemer Jaguar Health MVID Réunion De La FDA Procès Aux Émirats Arabes Unis
BRIEF

published on 10/06/2025 at 15:05, 8 months 19 days ago

Jaguar Health Advances Development with FDA Meeting on Crofelemer for MVID Treatment

Crofelemer Jaguar Health MVID FDA Meeting UAE Trial
PRESS RELEASE

published on 10/06/2025 at 15:00, 8 months 19 days ago

Jaguar Health Completes Meeting with FDA for Advice on Development Pathways to Advance Ongoing Crofelemer Trial for Potential Approval for Treatment of Pediatric Indication Microvillus Inclusion Disease (MVID)
Napo Pharmaceuticals provides update on ongoing clinical trial for the treatment of MVID in pediatric patients, showing significant reduction in parenteral support in UAE. FDA advice sought for study advancement

FDA Napo Pharmaceuticals Clinical Trial Pediatric Patients MVID
BRIEF

published on 09/30/2025 at 15:05, 8 months 25 days ago

Jaguar Health fournit Crofelemer pour le traitement de l'insuffisance intestinale pédiatrique

Crofelemer Jaguar Health Maladie D'inclusion Microvillositaire Traitement Pédiatrique Programmes De La FDA
BRIEF

published on 09/30/2025 at 15:05, 8 months 25 days ago

Jaguar Health Provides Crofelemer for Pediatric Intestinal Failure Treatment

Crofelemer Microvillus Inclusion Disease Jaguar Health Pediatric Treatment FDA Programs
PRESS RELEASE

published on 09/30/2025 at 15:00, 8 months 25 days ago

FDA-Authorized Expanded Access Programs Utilizing Jaguar Health's Novel Crofelemer Powder for Oral Solution to Treat Two Pediatric Intestinal Failure Patients with Microvillus Inclusion Disease
Jaguar Health announces expanded access programs for pediatric patients with microvillus inclusion disease using crofelemer powder. Positive results from initial trials presented

Microvillus Inclusion Disease Jaguar Health Pediatric Patients Crofelemer Powder Expanded Access Programs
BRIEF

published on 09/26/2025 at 12:22, 8 months 29 days ago

Jaguar Health Inc's Stock Recommendation Reiterated as BUY

Funding Jaguar Health Stock Recommendation Rare Diseases First Berlin
BRIEF

published on 09/26/2025 at 12:22, 8 months 29 days ago

Jaguar Health Inc. réitère sa recommandation d'achat sur ses actions

Financement Jaguar Health Maladies Rares Premier Berlin Recommandation D'actions
PRESS RELEASE

published on 09/26/2025 at 12:17, 8 months 29 days ago

Original-Research: Jaguar Health Inc (von First Berlin Equity Research GmbH): BUY
First Berlin Equity Research updates recommendation for Jaguar Health Inc to BUY with a target price of USD 35. Company reports H1/25 results in line with estimates, focuses on securing funding for promising pipeline

Jaguar Health Inc Funding First Berlin Equity Research Buy Recommendation Research Update

Accesswire

Published on 06/26/2026 at 01:40, 10 hours 2 minutes ago

UraniumX Announces DTC Eligibility for U.S. Traded Shares
Published on 06/25/2026 at 23:30, 12 hours 12 minutes ago

Zeus North America Mining Corp. Signs Option Agreement to Acquire Mining Claims in Idaho
Published on 06/25/2026 at 22:30, 13 hours 12 minutes ago

Fountain Asset Corp. Provides Corporate Update
Published on 06/25/2026 at 21:32, 14 hours 10 minutes ago

BlackBerry Announces Election Results for the Company's Board of Directors
Published on 06/25/2026 at 15:30, 20 hours 12 minutes ago

Silver Spruce Resources, Inc. Adds Mining, Energy, and Finance Development Expertise to the Board and Announces Director Resignation

View all ACCESSWIRE

EQS Group

Published on 06/26/2026 at 11:30, 12 minutes ago

Amundi Index Solutions: NOTICE TO SHAREHOLDERS
Published on 06/26/2026 at 11:14, 27 minutes ago

EQS-Adhoc: Evonik Industries AG: Current financial and forecast data for the second quarter of 2026 and adjustment of the outlook for the financial year 2026
Published on 06/26/2026 at 11:05, 36 minutes ago

Join the Beautiful Game: Discover Immersive Fan Experiences with Hisense at FIFA World Cup 2026™
Published on 06/26/2026 at 10:59, 43 minutes ago

HELIOS SOLAR AG starts subscription period for Initial Public Offering – shares offered at EUR 4.00
Published on 06/26/2026 at 10:50, 51 minutes ago

Indotek Group acquires remaining 53% stake in Auchan Hungary, assumes full ownership

Les Echos

Published on 06/26/2026 at 07:00, 4 hours 42 minutes ago

Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/26/2026 at 07:00, 4 hours 42 minutes ago

Améliorer la santé des femmes grâce au diagnostic rapide : bioMérieux dépose auprès de la FDA une demande combinée d’autorisation 510(k) et de dérogation CLIA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/25/2026 at 18:45, 16 hours 57 minutes ago

Avis Financier Semestriel SFCMC au 30 avril 2026
Published on 06/25/2026 at 18:30, 17 hours 12 minutes ago

Avis financier semestriel SIEHM au 30 avril 2026
Published on 06/25/2026 at 17:50, 17 hours 52 minutes ago

DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS

View all LES ECHOS COMFI WIRE